Alto Neuroscience
Curated by SignalAI-driven drug discovery platform for neurological diseases based on patients biomarkers
Overview
AI-driven drug discovery platform for neurological diseases based on patients biomarkers. The company's platform measures patients biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to develop personalized psychiatric drugs. The company has pipeline of drugs including ALTO-100 for depression, ALTO-101 for neurodegenerative diseases, and more.
Key facts
- Founded
- 2019
- Headquarters
- San Francisco, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
Open roles
25 rolesAssociate Director, Clinical Operations: People & Functional Leadership
Mountain View, CA · On-site · Volunteer
Manager, Patient Recruitment & Engagement
Mountain View, CA · On-site · Volunteer
Senior Manager/Director of Procurement
Mountain View, CA · On-site · Volunteer